bioMerieux, Inc. · Class II · Cleared Feb 16, 2023
| K-number | K223478 |
| Device name | VITEK® 2 AST-Gram Negative Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin (=0.5 - =16 µg/mL); VITEK® 2 AST-GN Plazomicin |
| Applicant | bioMerieux, Inc. |
| Product code | LON |
| Device class | Class II |
| Decision date | Feb 16, 2023 |
| Decision | Substantially Equivalent |
| Regulation | 866.1645 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov